ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED

Zhongzhi Pharmaceutical Holdings Limited

3737

KYG989611085

Pharmaceuticals

Delayed Hong Kong S.E. Other stock markets 04:08:08 2026-06-25 EDT			5-day change	1st Jan Change
0.7100 ^HKD	0.00%		+1.43%	+26.79%

03-26	Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-26	Zhongzhi Pharmaceutical Holdings Limited Recommends No Dividend for the Year Ended December 31, 2025	CI

Zhongzhi pharmaceutical expects over 70% decrease in 2025 net profit

Published on 01/23/2026 at 10:37 am EST

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Zhongzhi Pharmaceutical Holdings Limited

03-26	Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-26	Zhongzhi Pharmaceutical Holdings Limited Recommends No Dividend for the Year Ended December 31, 2025	CI
02-13	Beijing FindCure Biosciencs Technology Co., Ltd. announced that it has received CNY 100 million in funding from Zhuhai Hecheng Zhiyi Capital Management Co., Ltd., Zhongshan Jianzhuo Venture Capital Fund Partnership (Limited Partnership), Hubei Renxi Science and Technology Innovation Industry Investment Private Equity Fund Management Co., Fengyang Jialu Investment, Zhongzhi Pharmaceutical Holdings Limited	CI
02-13	FindCure Biosciences Co., Ltd. announced that it has received CNY 100 million in funding from Zhuhai Hecheng Zhiyi Capital Management Co., Ltd., Zhongzhi Pharmaceutical Holdings Limited and other investors	CI
01-25	Zhongzhi Pharmaceutical Flags Over 70% Drop in 2025 Net Profit; Shares Slip 5%	MT
01-23	Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025	CI
01-23	Zhongzhi pharmaceutical expects over 70% decrease in 2025 net profit	RE
25-08-26	Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-07-18	Zhongzhi pharmaceutical expects 90% decrease in HY net profit	RE
25-07-18	Zhongzhi Pharmaceutical Warns of 90% Drop in H1 Profit	MT
25-07-18	Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2025	CI
25-05-13	Zhongzhi Pharmaceutical Holdings Limited Approves Dividend	CI
25-04-10	Zhongzhi Pharmaceutical Holdings Limited Announces Board and Committee Changes, Effective 10 April 2025	CI
25-03-26	Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2024, Payable on 19 June 2025	CI
25-03-26	Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Chart Zhongzhi Pharmaceutical Holdings Limited

Duration

Period

Chart Zhongzhi Pharmaceutical Holdings Limited

3737: Dynamic Chart

Zhongzhi Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceutical products. The Company's products mainly comprise Chinese patent medicines and decoction pieces, mainly consisting of traditional decoction pieces and modern decoction pieces. The Company operates through two segments, including the Pharmaceutical Manufacturing segment and Operation of the Chain Pharmacies segment. The Company owns brands such as Zhongzhi, Liumian and Caojinghua. The Company mainly conducts its businesses in the domestic market.

Employees

2,284

Sector

Pharmaceuticals

More about the company